Search research articles
Contact Us
Filters
Showing results (111-120 of 142) with videos related to
Page
of 15
Sort By:
The Journal of Headache and Pain
|
April 3, 2026
DNA methylation signatures of treatment response in medication-overuse headache
Katarzyna Malgorzata Kwiatkowska, Valentina Favoni, Francesca Ferraresi, et al.
The Journal of Headache and Pain
|
March 28, 2026
Epimutations in migraine and in medication overuse headache: a longitudinal study after acute medication withdrawal
Francesca Ferraresi, Valentina Favoni, Davide Mascarella, et al.
Journal of Neurology
|
January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Piero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
European Journal of Neurology
|
September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study
Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Journal of Neurology
|
October 8, 2020
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Lorenzo Muccioli, Umberto Pensato, Giorgia Bernabè, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 16, 2018
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire
Venusia Covelli, Erika Guastafierro, Alberto Raggi, et al.
The Journal of Headache and Pain
|
September 12, 2018
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire
Alberto Raggi, Venusia Covelli, Erika Guastafierro, et al.
Journal of Neurology
|
July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Fabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Fluids and Barriers of the CNS
|
June 24, 2026
Alzheimer's disease core biomarkers are associated with worse baseline and postoperative cognitive profiles in idiopathic normal pressure hydrocephalus: findings from the Bologna PRO-Hydro study
Chiara Riccietti, Luisa Sambati, Corrado Zenesini, et al.
The Journal of Headache and Pain
|
November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 142) with videos related to
Sort By:
Page
of 15
The Journal of Headache and Pain
|
April 3, 2026
DNA methylation signatures of treatment response in medication-overuse headache
Katarzyna Malgorzata Kwiatkowska, Valentina Favoni, Francesca Ferraresi, et al.
The Journal of Headache and Pain
|
March 28, 2026
Epimutations in migraine and in medication overuse headache: a longitudinal study after acute medication withdrawal
Francesca Ferraresi, Valentina Favoni, Davide Mascarella, et al.
Journal of Neurology
|
January 25, 2025
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Piero Barbanti, Cinzia Aurilia, Paola Torelli, et al.
European Journal of Neurology
|
September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study
Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Journal of Neurology
|
October 8, 2020
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Lorenzo Muccioli, Umberto Pensato, Giorgia Bernabè, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 16, 2018
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire
Venusia Covelli, Erika Guastafierro, Alberto Raggi, et al.
The Journal of Headache and Pain
|
September 12, 2018
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire
Alberto Raggi, Venusia Covelli, Erika Guastafierro, et al.
Journal of Neurology
|
July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Fabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Fluids and Barriers of the CNS
|
June 24, 2026
Alzheimer's disease core biomarkers are associated with worse baseline and postoperative cognitive profiles in idiopathic normal pressure hydrocephalus: findings from the Bologna PRO-Hydro study
Chiara Riccietti, Luisa Sambati, Corrado Zenesini, et al.
The Journal of Headache and Pain
|
November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Page
of 15